Revotek Co., Ltd. products

It is estimated by the World Health Organization that the current global prevalence of advanced vascular disease is ~175mm people and increasing. One of the most common clinical interventions to treat advanced vascular disease is the replacement of stenotic or occluded arteries with vascular grafts. This is often accomplished utilizing autologous veins/arteries or through synthetic conduits composed of materials such as polyester or expanded polytetrafluoroethylene (ePTFE).

Biosynsphere™ is a proprietary bio-ink preparation that enables scaffold-free printing and allows cells to maintain their autologous nature during the fabrication process. Each sphere contains a micro environment housing the cells, nutrients, and cytokines.